Approximately 1 mg/mL of sample was mixed with the matrix at a ratio of 1:1 (v/v). 1 µl of mixture was spotted on a stainless steel plate and analyzed according to manufacturer instructions.
2 images were obtained using Nanoscope IIIA AFM (Digital Instruments, Santa Barbara, CA) in tapping mode, operating in an ambient atmosphere.
Particle Size and Charge
The particle size was measured by dynamic light scattering using 90 Plus Particle Size Analyzer (Brookhaven Instruments Corp., New York, NY). To characterize a surface change of nanoparticles, zeta potential was measured using PALS Zeta Potential Analyzer (Brookhaven Instruments Corp., Holtsville, NY).
Stability of the Complexes in Serum
Serum stability of naked siRNA and siRNA complexated with PPI dendrimer and protected by DTBP caging were investigated by incubating siRNA or PPI-siRNA complex in 50% human serum at 37 ºC as described (3) 
Cell Invasion Assay
The cell invasion assay was performed using Corning 96 well HTS Transwell® permeable supports (Corning, Corning, NY). Briefly, the transwells were first coated with 0.2x Basal Membrane Extract (BME) (Trevigen, Gaithersburg, MD). 1·10 
In Vitro Cytotoxicity
A modified MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tertrazolium bromide) assay was utilized to evaluate the cytotoxicity of the nanoparticles as previously described (7, 8 
In Vivo Body Distribution
The distribution of fluorescent-labeled non-targeted and LHRH tumor-targeted PPI dendrimer was examined in mouse tumor, lungs, heart, liver, spleen, kidneys, and brain as previously described (3, (9) (10) (11) (12) (13) . The organs were excised, rinsed in saline, 
